Clinical research and infection prevention
Theme Leaders
Description
Clinical research and infection prevention and planning is needed to help healthcare professionals understand the severity of each disease, who is susceptible and how best to assist people who are affected.
Related Projects
- ‘First Few X’ (FFX) research project to enhance the public health response to COVID-19 in Australia
- AuStralian COVID Trial (ASCOT)
- Establishing a national biobank for COVID-19
- Evaluating video-reflexive methods to improve infection prevention and use of personal protective equipment in Australian hospitals
- Frequently Asked Questions – ‘First Few X’ (FFX) project to enhance the public health response to COVID-19 in Australia
- Human parechovirus 3 (HPeV3) recombinant strain diversity and severe disease association in Australian outbreaks
- National and targeted sero-surveys of population immunity to SARS-COV2 to inform clinical and public health responses
- REMAP-CAP for COVID 19
- Sentinel Travellers and Research Preparedness Platform for Emerging Infectious Disease (SETREP-ID)
- Short PeRiod IncideNce sTudy of Severe Acute Respiratory Infection (SPRINT-SARI): research preparedness for pandemics
- The interaction between influenza and SARS-CoV-2 in nursing homes
- Understanding host response of severe viral pneumonitis
- Understanding stakeholder beliefs, attitudes and responses to COVID-19 infection prevention and control (IPC): a multimodal qualitative study
Related Publications
- Nafamostat mesylate for treatment of COVID-19 in hospitalised patients: A structured, narrative review
- Anticoagulation strategies in non–critically ill patients with Covid-19
- Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study
- An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients
- Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study
- ISARIC-COVID-19 dataset: A prospective, standardized, global dataset of patients hospitalized with COVID-19
- The value of open-source clinical science in pandemic response: lessons from ISARIC
- Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study
- Exploring healthcare workers’ perspectives of video feedback for training in the use of powered air purifying respirators (PAPR) at the onset of the COVID-19 pandemic
- ‘Like building a plane and flying it all in one go’: an interview study of infection prevention and control in Australian general practice during the first 2 years of the SARS-CoV-2 pandemic
- People in intensive care with COVID-19: demographic and clinical features during the first, second, and third pandemic waves in Australia
- Timing and temporal trends of influenza and pertussis vaccinations during pregnancy in three Australian jurisdictions: The Links2HealthierBubs population-based linked cohort study, 2012–2017
- Paradoxes of pandemic infection control: Proximity, pace and care within and beyond SARS-CoV-2
- Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: A randomized clinical trial
- Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol
- Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-specific antibodies in Australia after the first epidemic wave in 2020: A national survey
- Experiences of the SARS-CoV-2 pandemic amongst Australian Healthcare workers: From stressors to protective factors
- Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19. A randomized clinical trial
- Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
- Essential Emergency and Critical Care: a consensus among global clinical experts
- Entanglements of affect, space, and evidence in pandemic healthcare: An analysis of Australian healthcare workers’ experiences of COVID-19
- Testing the efficacy and acceptability of video-reflexive methods in personal protective equipment training for medical interns: a mixed methods study
- Neonatal parechovirus infection: Possibility of in-utero transmission
- Therapeutic anticoagulation with heparin in critically ill patients with Covid-19
- Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19
- Australia needs a prioritised national research strategy for clinical trials in a pandemic: lessons learned from COVID-19
- Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19)
- Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
- Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study
- Interleukin-6 receptor antagonists in critically ill patients with Covid-19
- Hospital outcomes after a COVID-19 diagnosis from January to May 2020 in New South Wales Australia
- Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic
- Education and training in infection prevention and control: Exploring support for national standards
- COVID-19 public health measures and respiratory syncytial virus
- COVID‐19 in a Sydney nursing home: a case study and lessons learnt
- Hospital Infection Prevention and Control (IPC) and Antimicrobial Stewardship (AMS): Dual strategies to reduce antibiotic resistance (ABR) in hospitals
- Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19. The REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
- Medical interns’ reflections on their training in use of personal protective equipment
- Geospatial epidemiology of Staphylococcus aureus in a tropical setting: an enabling digital surveillance platform
- Attributable length of stay, mortality risk and costs of bacterial healthcare-associated infections in Australia: a retrospective case-cohort study
- Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study
- Rapid research report – The most promising therapeutics for COVID-19
- Trajectories of hospital infection control: Using non-representational theory to understand and improve infection prevention and control
- Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
- Breadth of concomitant immune responses underpinning viral clearance and patient recovery in a non-severe case of COVID-19
- Hospital infection control: old problem – evolving challenges
- Enablers of, and barriers to, optimal glove and mask use for routine care in the emergency department: an ethnographic study of Australian clinicians
- Causes and clinical features of childhood encephalitis: A multicenter, prospective cohort study
- Presenteeism among health care workers with laboratory-confirmed influenza infection: A retrospective cohort study in Queensland, Australia
- Parechovirus A infections in healthy Australian children during the first 2-years of life: a community-based longitudinal birth cohort study
- Priority needs for conducting pandemic-relevant clinical research with children in Europe: A consensus study with pediatric clinician-researchers
- Evolutionary analysis of human parechovirus type 3 and clinical outcomes of infection during the 2017-18 Australian epidemic
- Influenza and pertussis vaccination of women during pregnancy in Victoria, 2015–2017
- Communicable disease surveillance ethics in the age of big data and new technology
- Perspectives of Australian policy-makers on the potential benefits and risks of technologically enhanced communicable disease surveillance – a modified Delphi survey
- Clinician perceptions of respiratory infection risk; a rationale for research into mask use in routine practice
- Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2017: Results from the PAEDS-FluCAN Collaboration
- The impact of influenza infection on young children, their family and the health care system
- Role of viral and bacterial pathogens in causing pneumonia among Western Australian children: a case-control study protocol
- Recruiting general practice patients for large clinical trials: lessons from the Aspirin in Reducing Events in the Elderly (ASPREE) study
- Book: Video-reflexive ethnography in health research and healthcare improvement
- Clinical research networks and assessing pandemic severity
- Presentation: A mixed methods study of the risk-taking behaviour of clinical staff towards routine use of protective masks for infectious diseases
- Presentation: Talking with patients: Improving clinician-patient communication around healthcare-associated infections using video-reflexive methods
- Presentation: Keeping our hospitals safe from exotic infections
- Characterising seasonal influenza epidemiology using primary care surveillance data
- To follow a rule? On frontline clinicians’ understandings and embodiments of hospital-acquired infection prevention and control rules
- Parechovirus: an important emerging infection in young infants
- Bending the pandemic curve: Improving decision-making with clinical research
- Plenary presentation: Pandemics cross borders: How to tackle them from a global perspective
- Stakeholder Consultation Report – Australian Partnership for Preparedness Research on Infectious Disease Emergencies: NHMRC Centre for Research Excellence
- Webinar – Managing uncertainty in clinical trials: the role of adaptive trial designs
- Is Australia prepared for the next pandemic?
- Developing research priorities for Australia’s response to infectious disease emergencies